Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p1163 has 77 genes in the original annotation. Currently, there are 57 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
5599	MAPK8	JNK \| JNK-46 \| JNK1 \| JNK1A2 \| JNK21B1/2 \| PRKM8 \| SAPK1 \| SAPK1c	mitogen-activated protein kinase 8	10q11.22
983	CDK1	CDC2 \| CDC28A \| P34CDC2	cyclin-dependent kinase 1	10q21.1
4791	NFKB2	CVID10 \| H2TF1 \| LYT-10 \| LYT10 \| NF-kB2 \| p100 \| p49/p100 \| p52	nuclear factor of kappa light polypeptide gene enhancer in B-cells 2	10q24
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
7189	TRAF6	MGC:3310 \| RNF85	TNF receptor associated factor 6	11p12
6288	SAA1	PIG4 \| SAA \| SAA2 \| TP53I4	serum amyloid A1	11p15.1
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
246330	PELI3	-	pellino E3 ubiquitin protein ligase family member 3	11q13.2
466	ATF1	EWS-ATF1 \| FUS/ATF-1 \| TREB36	activating transcription factor 1	12q13
1848	DUSP6	HH19 \| MKP3 \| PYST1	dual specificity phosphatase 6	12q21.33
7334	UBE2N	HEL-S-71 \| UBC13 \| UBCHBEN; UBC13 \| UbcH-ben \| UbcH13	ubiquitin conjugating enzyme E2 N	12q22
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
57161	PELI2	-	pellino E3 ubiquitin protein ligase family member 2	14q21
2353	FOS	AP-1 \| C-FOS \| p55	FBJ murine osteosarcoma viral oncogene homolog	14q24.3
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
4205	MEF2A	ADCAD1 \| RSRFC4 \| RSRFC9 \| mef2	myocyte enhancer factor 2A	15q26
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
64127	NOD2	ACUG \| BLAU \| CARD15 \| CD \| CLR16.3 \| IBD1 \| NLRC2 \| NOD2B \| PSORAS1	nucleotide binding oligomerization domain containing 2	16q21
5598	MAPK7	BMK1 \| ERK4 \| ERK5 \| PRKM7	mitogen-activated protein kinase 7	17p11.2
5606	MAP2K3	MAPKK3 \| MEK3 \| MKK3 \| PRKMK3 \| SAPKK-2 \| SAPKK2	mitogen-activated protein kinase kinase 3	17q11.2
1845	DUSP3	VHR	dual specificity phosphatase 3	17q21
5608	MAP2K6	MAPKK6 \| MEK6 \| MKK6 \| PRKMK6 \| SAPKK-3 \| SAPKK3	mitogen-activated protein kinase kinase 6	17q24.3
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
5609	MAP2K7	JNKK2 \| MAPKK7 \| MEK \| MEK 7 \| MKK7 \| PRKMK7 \| SAPKK-4 \| SAPKK4	mitogen-activated protein kinase kinase 7	19p13.3-p13.2
4793	NFKBIB	IKBB \| TRIP9	NFKB inhibitor beta	19q13.1
5518	PPP2R1A	MRD36 \| PP2A-Aalpha \| PP2AAALPHA \| PR65A	protein phosphatase 2 regulatory subunit A, alpha	19q13.41
6195	RPS6KA1	HU-1 \| MAPKAPK1A \| RSK \| RSK1 \| p90Rsk	ribosomal protein S6 kinase A1	1p
6283	S100A12	CAAF1 \| CAGC \| CGRP \| ENRAGE \| MRP-6 \| MRP6 \| p6	S100 calcium binding protein A12	1q21
9261	MAPKAPK2	MAPKAP-K2 \| MK-2 \| MK2	mitogen-activated protein kinase-activated protein kinase 2	1q32
387522	TMEM189-UBE2V1	CROC-1B \| CROC1B \| KUA-UEV	TMEM189-UBE2V1 readthrough	20q13.2
351	APP	AAA \| ABETA \| ABPP \| AD1 \| APPI \| CTFgamma \| CVAP \| PN-II \| PN2	amyloid beta precursor protein	21q21.3
6285	S100B	NEF \| S100 \| S100-B \| S100beta	S100 calcium binding protein B	21q22.3
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
10454	TAB1	3'-Tab1 \| MAP3K7IP1	TGF-beta activated kinase 1/MAP3K7 binding protein 1	22q13.1
5600	MAPK11	P38B \| P38BETA2 \| PRKM11 \| SAPK2 \| SAPK2B \| p38-2 \| p38Beta	mitogen-activated protein kinase 11	22q13.33
1386	ATF2	CRE-BP1 \| CREB-2 \| CREB2 \| HB16 \| TREB7	activating transcription factor 2	2q32
1385	CREB1	CREB \| CREB-1	cAMP responsive element binding protein 1	2q34
1849	DUSP7	MKPX \| PYST2	dual specificity phosphatase 7	3p21
7867	MAPKAPK3	3PK \| MAPKAP-K3 \| MAPKAP3 \| MAPKAPK-3 \| MK-3	mitogen-activated protein kinase-activated protein kinase 3	3p21.3
54106	TLR9	CD289	toll like receptor 9	3p21.3
4615	MYD88	MYD88D	myeloid differentiation primary response 88	3p22
5602	MAPK10	JNK3 \| JNK3A \| PRKM10 \| SAPK1b \| p493F12 \| p54bSAPK	mitogen-activated protein kinase 10	4q22.1-q23
4214	MAP3K1	MAPKKK1 \| MEKK \| MEKK 1 \| MEKK1 \| SRXY6	mitogen-activated protein kinase kinase kinase 1	5q11.2
4208	MEF2C	C5DELq14.3 \| DEL5q14.3	myocyte enhancer factor 2C	5q14.3
5515	PPP2CA	PP2Ac \| PP2CA \| PP2Calpha \| RP-C	protein phosphatase 2 catalytic subunit alpha	5q31.1
177	AGER	RAGE	advanced glycosylation end product-specific receptor	6p21.3
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
6885	MAP3K7	MEKK7 \| TAK1 \| TGF1a	mitogen-activated protein kinase kinase kinase 7	6q15
6196	RPS6KA2	HU-2 \| MAPKAPK1C \| RSK \| RSK3 \| S6K-alpha \| S6K-alpha2 \| p90-RSK3 \| p90RSK2 \| pp90RSK3	ribosomal protein S6 kinase A2	6q27
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
1846	DUSP4	HVH2 \| MKP-2 \| MKP2 \| TYP	dual specificity phosphatase 4	8p12-p11
8767	RIPK2	CARD3 \| CARDIAK \| CCK \| GIG30 \| RICK \| RIP2	receptor interacting serine/threonine kinase 2	8q21
2002	ELK1	-	ELK1, ETS transcription factor	Xp11.2
51311	TLR8	CD288	toll like receptor 8	Xp22
6197	RPS6KA3	CLS \| HU-3 \| ISPK-1 \| MAPKAPK1B \| MRX19 \| RSK \| RSK2 \| S6K-alpha3 \| p90-RSK2 \| pp90RSK2	ribosomal protein S6 kinase A3	Xp22.2-p22.1
51284	TLR7	TLR7-like	toll like receptor 7	Xp22.3
3654	IRAK1	IRAK \| pelle	interleukin 1 receptor associated kinase 1	Xq28